*Applications will be reviewed on a rolling-basis, and this opportunity will remain open until filled.
A research opportunity is currently available in the Office of Tissue and Advanced Therapeutics (OTAT) at the Center for Biologics Evaluation and Research (CBER), Food and Drug Administration (FDA) in Silver Spring, Maryland.
This fellowship will be focused on investigating the biochemical mechanisms of human blood coagulation, to enhance the safety and efficacy of products that treat blood coagulation disorders. The successful candidate will receive mentoring on fulfilling the project, which will also include collaboration with investigators within and external to the FDA.
The following papers provide examples of the research work performed in our group:
1. Chun H, et al (2022) Blood coagulation factor VIII and LRP1 interact dynamically via switching alternative canonical bivalent and non-canonical electrostatic contacts. J. Thromb. Haemost. 20(10):2255-69.
2. Shestopal SA, et al (2022) Isolated variable domains of an antibody can assemble on blood coagulation factor VIII into functional Fv-like complex. Int. J. Mol. Sci. 23(15):8134.
3. Marakasova ES, et al. (2021) Molecular chaperone RAP interacts with LRP1 in a dynamic bivalent mode and enhances folding of the ligand-binding regions of LDLR family receptors. J. Biol. Chem. 297(1):100842-59.
4. Chun H, et al. (2021). Characterization of protein unable to bind von Willebrand factor in recombinant factor VIII products. J. Thromb. Haemost. 19(4):954-66.
5. Shestopal SA, et al. Expression and characterization of a codon-optimized blood coagulation factor VIII. J Thromb Haemost. 2017;15(4):709-20.
6. Kurasawa JH, et al. Mapping the Binding Region on the Low Density Lipoprotein Receptor for Blood Coagulation Factor VIII. J Biol Chem. 2013;288(30):22033-41.
7. Kurasawa JH, et al. Cluster III of low-density lipoprotein receptor-related protein 1 binds activated blood coagulation factor VIII. Biochemistry. 2015;54(2):481-9.
8. Kurasawa JH, et al. Insect cell-based expression and characterization of a single-chain variable antibody fragment directed against blood coagulation factor VIII. Protein Expr Purif. 2013;88:201-6.
Anticipated Appointment Start Date: May 1, 2023; start date is flexible
This program, administered by ORAU through its contract with the U.S. Department of Energy to manage the Oak Ridge Institute for Science and Education, was established through an interagency agreement between DOE and FDA. The initial appointment is for four months, but may be renewed upon recommendation of FDA contingent on the availability of funds. The participant will receive a monthly stipend commensurate with educational level and experience. Proof of health insurance is required for participation in this program. The appointment is full-time at FDA in the Silver Spring, Maryland, area. Participants do not become employees of FDA, DOE or the program administrator, and there are no employment-related benefits.
Completion of a successful background investigation by the Office of Personnel Management is required for an applicant to be on-boarded at FDA. OPM can complete a background investigation only for individuals, including non-US Citizens, who have resided in the US for a total of three of the past five years.
FDA requires ORISE participants to read and sign their FDA Education and Training Agreement within 30 days of his/her start date, setting forth the conditions and expectations for his/her educational appointment at the agency. This agreement covers such topics as the following:
- Non-employee nature of the ORISE appointment;
- Prohibition on ORISE Fellows performing inherently governmental functions;
- Obligation of ORISE Fellows to convey all necessary rights to the FDA regarding intellectual property conceived or first reduced to practice during their fellowship;
- The fact that research materials and laboratory notebooks are the property of the FDA;
- ORISE fellow’s obligation to protect and not to further disclose or use non-public information.
Similar Positions
-
Clinical Research Study Assistant Ii Obstetrics And Gynecology, University of Washington, United States, 14 days ago
Scheduled Hours 40 Position Summary This position will support research activities with pregnant patients being seen in community-based health clinics. This position will also be responsible for e...
-
Post Doctoral Associate, University of Maryland, United States, 1 day ago
Posting Details Posting Details Position Number: 124830 Title: Post-Doctoral Associate Functional Title: Post-Doctoral Associate Category Status: 15-Fac.Non-Tenured,Continuing Con Applicant Search...
-
Post Doctoral Associate, University of Maryland, United States, about 16 hours ago
Posting Details Posting Details Position Number: 123244 Title: Post-Doctoral Associate Functional Title: Post-Doctoral Associate Category Status: 15-Fac.Non-Tenured,Continuing Con Applicant Search...
-
Research Assistant, Virginia Tech, United States, about 1 hour ago
The Mulvaney Lab located in Washington, DC focuses on studying and therapeutically targeting enzyme-substrate interactions in cancer. We are seeking a research assistant (lab technician) who is cr...
-
Post Doctoral Associate, University of Maryland, United States, about 16 hours ago
Posting Details Posting Details Position Number: 129344 Title: Post-Doctoral Associate Functional Title: Post-doctoral Associate Category Status: 15-Fac.Non-Tenured,Continuing Con Applicant Search...
-
Postdoctoral Researcher (Prep0002351), Johns Hopkins University, United States, 20 days ago
Details Posted: 06-Apr-24 Location: Gaithersburg, Maryland Type: Full-time Salary: Open Categories: Academic/Faculty Other - Academic/Faculty Internal Number: A-143992-26 General Description This ...